- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cocrystal Pharma Inc (COCP)
Assess today's live Cocrystal Pharma Inc (COCP) share price, performance and insights using our live NASDAQ: COCP stock exchange data.
Analyse the historical data and Cocrystal Pharma Inc share price performance charts on this page. Our technical summary section provides analysis on Cocrystal Pharma share price buy/sell indicators using real-time data (or discuss the Cocrystal Pharma (COCP) stock price today with other investors in the Cocrystal Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ COCP share price (ISIN: US19188J4094) to enhance your trading decisions with our free investment tools and resources.
What Is the Cocrystal Pharma Inc Share Price Today?
The Cocrystal Pharma share price today is 1.0400.
What Is the Stock Symbol for Cocrystal Pharma Inc
The stock symbol (or 'ticker') for Cocrystal Pharma Inc is "COCP."
What Stock Exchange Does Cocrystal Pharma Inc Trade On?
Cocrystal Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Cocrystal Pharma Inc a Good Stock to Buy?
Determining whether Cocrystal Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Cocrystal Pharma Inc share price performance charts on this page. Our technical summary section provides analysis on Cocrystal Pharma share price buy/sell indicators using real-time data (or discuss the Cocrystal Pharma (COCP) stock price today with other investors in the Cocrystal Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ COCP share price (ISIN: US19188J4094) to enhance your trading decisions with our free investment tools and resources.
What Is the Cocrystal Pharma Inc Share Price Today?
The Cocrystal Pharma share price today is 1.0400.
What Is the Stock Symbol for Cocrystal Pharma Inc
The stock symbol (or 'ticker') for Cocrystal Pharma Inc is "COCP."
What Stock Exchange Does Cocrystal Pharma Inc Trade On?
Cocrystal Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Cocrystal Pharma Inc a Good Stock to Buy?
Determining whether Cocrystal Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
1.0400
-0.0200(-1.89%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0304
1.0600
52 wk Range
0.9000
2.6700
COCP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.03041.0600
52 wk Range
0.90002.6700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COCP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
8.0000
Upside
+669.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Form 8K Cocrystal Pharma Inc For: 18 December
- Investing.com
- Form 8K Cocrystal Pharma Inc For: 18 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cocrystal Pharma Company Profile
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, a HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was founded in 2006 and is based in Bothell, Washington.
Compare COCP to Peers and Sector
Metrics to compare | COCP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOCPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −2.1x | −0.6x | |
PEG Ratio | −0.03 | −0.20 | 0.00 | |
Price/Book | 1.9x | 1.3x | 2.6x | |
Price / LTM Sales | - | 2.6x | 3.4x | |
Upside (Analyst Target) | - | 174.7% | 40.5% | |
Fair Value Upside | Unlock | 23.1% | 4.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.0000
(+669.23% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-0.19 / -0.34
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Cocrystal Pharma (COCP) Share Price Today?
The live Cocrystal Pharma share price today is 1.0400
What Stock Exchange Does Cocrystal Pharma (COCP) Trade On?
Cocrystal Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Cocrystal Pharma?
The stock symbol (also called a 'ticker') for Cocrystal Pharma is "COCP."
What Is the Current Cocrystal Pharma Market Cap?
As of today, Cocrystal Pharma market capitalisation is 14.34M.
What Is Cocrystal Pharma's (COCP) Earnings Per Share (TTM)?
The Cocrystal Pharma EPS is currently -0.93 (Trailing Twelve Months).
Is COCP a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cocrystal Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cocrystal Pharma Stock Split?
Cocrystal Pharma has split 3 times. (See the COCP stock split history page for full effective split date and price information.)
How Many Employees Does Cocrystal Pharma Have?
Cocrystal Pharma has 11 employees.
What is the current trading status of Cocrystal Pharma (COCP)?
As of 23 Jan 2026, Cocrystal Pharma (COCP) is trading at a price of 1.0400, with a previous close of 1.0600. The stock has fluctuated within a day range of 1.0304 to 1.0600, while its 52-week range spans from 0.9000 to 2.6700.
What Is Cocrystal Pharma (COCP) Price Target According to Analysts?
The average 12-month price target for Cocrystal Pharma is USD8.0000, with a high estimate of USD10 and a low estimate of USD6. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +669.23% Upside potential.
What Is the COCP Premarket Price?
COCP's last pre-market stock price is 1.0692. The pre-market share volume is 580.0000, and the stock has decreased by 0.0092, or 0.8700%.
What Is the COCP After Hours Price?
COCP's last after hours stock price is 1.0100, the stock has decreased by -0.0500, or -4.7200%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.